Protalix BioTherapeutics, Inc Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (55)

Latest Posts

About This Stock More About This Stock
S Protalix PRX-102: Likely Approval Could Be A Game Changer
Article By: Shareholders Unite
Monday, May 2, 2022 9:02 AM EDT
Protalix's PRX-102 drug stands a good chance of being accepted against Fabry disease, with three P3 trials delivering good results.
In this article: PLX Also: PFE
Read
S Why Protalix Is Back On The Radar
Article By: Kate Hayden
Tuesday, April 19, 2022 8:55 AM EDT
After encountering bureaucratic hurdles, Protalix's PRX-102 has come through the BALANCE study with flying colors and is ready to reapply for its BLA.
In this article: PLX
Read
S Protalix BioTherapeutics: Management Sounds Confident Despite CRL
Article By: Avisol Capital Partners
Wednesday, January 5, 2022 9:39 AM EDT
A spate of bad bureacratic luck - including the FDA letter explaining that Covid kept them from doing an inspection - has put PLX's Fabry disease drug in an uncompetitive position, but we reached out to management to learn more about the pipeline.
In this article: PLX
Read
S PLX Upcoming Volatility Creates Opportunity
Article By: Moon Kil Woong
Tuesday, July 27, 2021 9:01 AM EDT
PLX was up on FDA notice last year on a CRL postponement that its PDUFA review of PRX-102. In the meantime, phase III trials continue to provide more positive results. It is a stock worth watching.
In this article: PLX Also: INO, DYAI, BCLI, LFMD
Read
Protalix: Leveraging Tech In Developing Therapies For Orphan Diseases
Article By: Ari Zoldan
Sunday, July 4, 2021 1:34 AM EDT
The company’s risk to reward scenario looks favorable, and we expect significant upside from current levels.
In this article: PLX Also: NVS, SNY, RHHBY, AMGN, CELG
Read

Latest Tweets for $PLX

No tweets yet!

PARTNER HEADLINES

$PLX

Why Protalix Is Back On The Radar
Kurt Benson 4/20/2022 10:43:37 AM

Bullish on $PLX.

Why Protalix Is Back On The Radar
Terrence Howard 4/19/2022 2:33:49 PM

$PLX has been on my radar for a while. Ever since Moon Kil Woong first wrote abuot it. I believe the stock shows tremendous promise and is quite affordable.

Protalix BioTherapeutics: Management Sounds Confident Despite CRL
Adam Reynolds 1/8/2022 7:57:42 PM

Seems like the CLR was completely unfair since it was the FDA that was unable to do the inspection.  That should not reflect negatively on $PLX at all.

Protalix BioTherapeutics: Management Sounds Confident Despite CRL
Terrence Howard 12/30/2021 4:58:14 PM

Good read, thanks.  Moon Kil Woong, you've often covered $PLX.  What's your take?

PLX Upcoming Volatility Creates Opportunity
IB Trading 7/27/2021 11:35:05 PM

Had our eyes on $PLX for a while now. I think big things are coming for this company.

There Is Beta In Protalix Stock Due To PRX-102
Stock Profit 8/31/2020 2:14:57 PM

I'm liking what I see about $PLX!

There Is Beta In Protalix Stock Due To PRX-102
Daniel Charles 8/31/2020 5:32:09 AM

Are there any other recombinant therapeutics that are in the pipeline for $PLX

There Is Beta In Protalix Stock Due To PRX-102
Cannabis Stock Buyer 8/31/2020 4:59:17 AM

I'll be taking a closer look at $PLX, thanks.

Protalix BioTherapeutics Pipeline Progress
Richard M. Clark 8/28/2020 2:40:47 AM

Just read another good article about $PLX out today:

There Is Beta In Protalix Stock Due To PRX-102

talkmarkets.com/.../there-is-beta-in-protalix-stock-due-to-prx-102

1 to 10 of 17 comments
1 2